|
1
|
Garcia-Albeniz X and Chan AT: Aspirin for
the prevention of colorectal cancer. Best Pract Res Clin
Gastroenterol. 25:461–472. 2011. View Article : Google Scholar
|
|
2
|
Lasham A, Samuel W, Cao H, et al: YB-1,
the E2F pathway, and regulation of tumor cell growth. J Natl Cancer
Inst. 104:133–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bommert KS, Effenberger M, Leich E, et al:
The feed-forward loop between YB-1 and MYC is essential for
multiple myeloma cell survival. Leukemia. 27:441–450. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takahashi M, Shimajiri S, Izumi H, et al:
Y-box binding protein-1 is a novel molecular target for tumor
vessels. Cancer Sci. 101:1367–1373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lovett DH, Cheng S, Cape L, Pollock AS and
Mertens PR: YB-1 alters MT1-MMP trafficking and stimulates MCF-7
breast tumor invasion and metastasis. Biochem Biophys Res Commun.
398:482–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi YK, Cho SG, Choi HS, Woo SM, Yun YJ,
Shin YC and Ko SG: JNK1/2 activation by an extract from the roots
of Morus alba L. reduces the viability of
multidrug-resistant MCF-7/Dox cells by inhibiting YB-1-dependent
MDR1 expression. Evid Based Complement Alternat Med.
2013:7419852013.PubMed/NCBI
|
|
7
|
Wu Y, Yamada S, Izumi H, et al: Strong
YB-1 expression is associated with liver metastasis progression and
predicts shorter disease-free survival in advanced gastric cancer.
J Surg Oncol. 105:724–730. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Panupinthu N, Yu S, Zhang D, et al:
Self-reinforcing loop of amphiregulin and Y-box binding protein-1
contributes to poor outcomes in ovarian cancer. Oncogene. Jul
15–2013.(Epub ahead of print).
|
|
9
|
Imada K, Shiota M, Kohashi K, et al:
Mutual regulation between Raf/MEK/ERK signaling and Y-box–binding
protein-1 promotes prostate cancer progression. Clin Cancer Res.
19:4638–4650. 2013.PubMed/NCBI
|
|
10
|
Khan MI, Adhami VM, Lall RK, et al: YB-1
expression promotes epithelial-to-mesenchymal transition in
prostate cancer that is inhibited by a small molecule fisetin.
Oncotarget. 5:2462–2474. 2014.PubMed/NCBI
|
|
11
|
Zhang H, Cheng S, Zhang M, et al:
Prostaglandin E2 promotes hepatocellular carcinoma cell invasion
through upregulation of YB-1 protein expression. Int J Oncol.
44:769–780. 2014.PubMed/NCBI
|
|
12
|
Franco-Chuaire ML, Magda Carolina SC and
Chuaire-Noack L: Epithelial-mesenchymal transition (EMT):
principles and clinical impact in cancer therapy. Invest Clin.
54:186–205. 2013.PubMed/NCBI
|
|
13
|
David JM and Rajasekaran AK: Dishonorable
discharge: the oncogenic roles of cleaved E-cadherin fragments.
Cancer Res. 72:2917–2923. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He X, Chen Z, Jia M and Zhao X:
Downregulated E-cadherin expression indicates worse prognosis in
Asian patients with colorectal cancer: evidence from meta-analysis.
PLoS One. 8:e708582013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Toiyama Y, Yasuda H, Saigusa S, Tanaka K,
Inoue Y, Goel A and Kusunoki M: Increased expression of Slug and
Vimentin as novel predictive biomarkers for lymph node metastasis
and poor prognosis in colorectal cancer. Carcinogenesis.
34:2548–2557. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Todosi AM, Gavrilescu MM, Aniţei GM, Filip
B and Scripcariu V: Colon cancer at molecular level - usefulness of
epithelial-mesenchymal transition analysis. Rev Med Chir Soc Med
Nat Iasi. 116:1106–1111. 2012.PubMed/NCBI
|
|
17
|
Evdokimova V, Tognon C, Ng T, et al:
Translational activation of snail1 and other developmentally
regulated transcription factors by YB-1 promotes an
epithelial-mesenchymal transition. Cancer Cell. 15:402–415. 2009.
View Article : Google Scholar
|
|
18
|
Shiota M, Yokomizo A, Itsumi M, et al:
Twist1 and Y-box-binding protein-1 promote malignant potential in
bladder cancer cells. BJU Int. 108:E142–E149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsushita K, Toiyama Y, Tanaka K, et al:
Soluble CXCL16 in preoperative serum is a novel prognostic marker
and predicts recurrence of liver metastases in colorectal cancer
patients. Ann Surg Oncol. 19(Suppl 3): S518–S527. 2012. View Article : Google Scholar
|
|
20
|
Tang FY, Pai MH and Chiang EP: Consumption
of high-fat diet induces tumor progression and
epithelial–mesenchymal transition of colorectal cancer in a mouse
xenograft model. J Nutr Biochem. 23:1302–1313. 2012.
|
|
21
|
Wu HM, Cao W, Ye D, Ren GX, Wu YN and Guo
W: Contactin 1 (CNTN1) expression associates with regional lymph
node metastasis and is a novel predictor of prognosis in patients
with oral squamous cell carcinoma. Mol Med Rep. 6:265–270.
2012.PubMed/NCBI
|
|
22
|
Tiwari N, Gheldof A, Tatari M and
Christofori G: EMT as the ultimate survival mechanism of cancer
cells. Semin Cancer Biol. 22:194–207. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bhangu A, Wood G, Mirnezami A, Darzi A,
Tekkis P and Goldin R: Epithelial mesenchymal transition in
colorectal cancer: Seminal role in promoting disease progression
and resistance to neoadjuvant therapy. Surg Oncol. 21:316–323.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu QC, Gao RY, Wu W and Qin HL:
Epithelial-mesenchymal transition and its role in the pathogenesis
of colorectal cancer. Asian Pac J Cancer Prev. 14:2689–2698. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lasham A, Print CG, Woolley AG, Dunn SE
and Braithwaite AW: YB-1: oncoprotein, prognostic marker and
therapeutic target? Biochem J. 449:11–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsofack SP, Garand C, Sereduk C, et al:
NONO and RALY proteins are required for YB-1 oxaliplatin induced
resistance in colon adenocarcinoma cell lines. Mol Cancer.
10:1452011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jürchott K, Kuban RJ, Krech T, et al:
Identification of Y-box binding protein 1 as a core regulator of
MEK/ERK pathway-dependent gene signatures in colorectal cancer
cells. PLoS Genet. 6:e10012312010.PubMed/NCBI
|
|
28
|
Hsieh AC, Liu Y, Edlind MP, et al: The
translational landscape of mTOR signalling steers cancer initiation
and metastasis. Nature. 485:55–61. 2012. View Article : Google Scholar
|
|
29
|
Schittek B, Psenner K, Sauer B, et al: The
increased expression of Y box-binding protein 1 in melanoma
stimulates proliferation and tumor invasion, antagonizes apoptosis
and enhances chemoresistance. Int J Cancer. 120:2110–2118. 2007.
View Article : Google Scholar
|
|
30
|
Sinnberg T, Sauer B, Holm P, Spangler B,
Kuphal S, Bosserfhoff A and Schittek B: MAPK and PI3K/AKT mediated
YB-1 activation promotes melanoma cell proliferation which is
counteracted by an autoregulatory loop. Exp Dermatol. 21:265–270.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Di Costanzo A, Troiano A, di Martino O, et
al: The p63 protein isoform ΔNp63α modulates Y-box binding protein
1 in its subcellular distribution and regulation of cell survival
and motility genes. J Biol Chem. 287:30170–30180. 2012.
|
|
32
|
To K, Fotovati A, Reipas KM, et al: Y-box
binding protein-1 induces the expression of CD44 and CD49f leading
to enhanced self-renewal, mammosphere growth, and drug resistance.
Cancer Res. 70:2840–2851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cho SH, Park YS, Kim HJ, et al: CD44
enhances the epithelial-mesenchymal transition in association with
colon cancer invasion. Int J Oncol. 41:211–218. 2012.PubMed/NCBI
|
|
34
|
Fujiwara-Okada Y, Matsumoto Y, Fukushi J,
et al: Y-box binding protein-1 regulates cell proliferation and is
associated with clinical outcomes of osteosarcoma. Br J Cancer.
108:836–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Evdokimova V, Tognon C, Ng T and Sorensen
PH: Reduced proliferation and enhanced migration: two sides of the
same coin? Molecular mechanisms of metastatic progression by YB-1.
Cell Cycle. 8:2901–2906. 2009. View Article : Google Scholar
|
|
36
|
Mouneimne G and Brugge JS: YB-1
translational control of epithelial-mesenchyme transition. Cancer
Cell. 15:357–359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo TT, Yu YN, Yip GW, Matsumoto K and Bay
BH: Silencing the YB-1 gene inhibits cell migration in gastric
cancer in vitro. Anat Rec (Hoboken). 296:891–898. 2013. View Article : Google Scholar : PubMed/NCBI
|
